CAPRICOR THERAPEUTICS, INC. Tax Credit Carryforward, Amount
CAPRICOR THERAPEUTICS, INC. (CAPR) had Tax Credit Carryforward, Amount of $40.90 million as of 2024-12-31, per its 10-K filed 2025-03-26.
Financial Statements › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardAmount · last filed 2025-03-26
- 2024-12-31: Tax Credit Carryforward, Amount $40.90M.
- 2023-12-31: Tax Credit Carryforward, Amount $50.70M.
- 2022-12-31: Tax Credit Carryforward, Amount $73.70M.
- 2021-12-31: Tax Credit Carryforward, Amount $76.10M.
| Period end | Tax Credit Carryforward, Amount |
|---|---|
| 2024-12-31 | $40.90M 10-K · filed 2025-03-26 |
| 2023-12-31 | $50.70M 10-K · filed 2024-03-11 |
| 2022-12-31 | $73.70M 10-K · filed 2023-03-17 |
| 2021-12-31 | $76.10M 10-K · filed 2022-03-11 |
| 2020-12-31 | $76.10M 10-K · filed 2021-03-15 |
| 2019-12-31 | $76.10M 10-K · filed 2020-03-27 |
| 2018-12-31 | $76.10M 10-K · filed 2019-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |